These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 2734298)
21. Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Larson KA; Olson EV; Madden BJ; Gleich GJ; Lee NA; Lee JJ Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12370-5. PubMed ID: 8901588 [TBL] [Abstract][Full Text] [Related]
22. The molecular biology of eosinophil granule proteins. Hamann KJ; Barker RL; Ten RM; Gleich GJ Int Arch Allergy Appl Immunol; 1991; 94(1-4):202-9. PubMed ID: 1657792 [TBL] [Abstract][Full Text] [Related]
23. Diversity among the primate eosinophil-derived neurotoxin genes: a specific C-terminal sequence is necessary for enhanced ribonuclease activity. Rosenberg HF; Dyer KD Nucleic Acids Res; 1997 Sep; 25(17):3532-6. PubMed ID: 9254715 [TBL] [Abstract][Full Text] [Related]
24. The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene. van Dijk TB; Caldenhoven E; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP Blood; 1998 Mar; 91(6):2126-32. PubMed ID: 9490699 [TBL] [Abstract][Full Text] [Related]
25. Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence. Handen JS; Rosenberg HF J Biol Chem; 1997 Jan; 272(3):1665-9. PubMed ID: 8999843 [TBL] [Abstract][Full Text] [Related]
30. GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene. Qiu Z; Dyer KD; Xie Z; Rådinger M; Rosenberg HF J Biol Chem; 2009 May; 284(19):13099-109. PubMed ID: 19279013 [TBL] [Abstract][Full Text] [Related]
31. Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin. Sikriwal D; Seth D; Batra JK Biol Chem; 2009 Mar; 390(3):225-34. PubMed ID: 19090717 [TBL] [Abstract][Full Text] [Related]
32. Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors. Leonidas DD; Boix E; Prill R; Suzuki M; Turton R; Minson K; Swaminathan GJ; Youle RJ; Acharya KR J Biol Chem; 2001 May; 276(18):15009-17. PubMed ID: 11154698 [TBL] [Abstract][Full Text] [Related]
33. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy. Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172 [TBL] [Abstract][Full Text] [Related]
34. Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14. Paul CC; Ackerman SJ; Mahrer S; Tolbert M; Dvorak AM; Baumann MA J Leukoc Biol; 1994 Jul; 56(1):74-9. PubMed ID: 8027673 [TBL] [Abstract][Full Text] [Related]
35. Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv. Newton DL; Nicholls PJ; Rybak SM; Youle RJ J Biol Chem; 1994 Oct; 269(43):26739-45. PubMed ID: 7929408 [TBL] [Abstract][Full Text] [Related]